David Clever

Mount Sinai Hospital — Canada

Immunology and Microbiology · Life Sciences

18h-index3.6kcitations75works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(26), CAR-T cell therapy research(14), Immunotherapy and Immune Responses(12), Cancer Immunotherapy and Biomarkers(11), Immune cells in cancer(9)

Publications75 total

LIMB-SALVAGE SURGERY AFTER UNPLANNED SURGERY FOR EXTREMITY BONE SARCOMAS: 30-YEAR EXPERIENCE AT A TERTIARY REFERRAL CENTRE
Orthopaedic Proceedings·2025
THE UTILITY OF INTRAOPERATIVE MARROW MARGIN FROZEN SECTION IN EXTREMITY BONE SARCOMA RESECTION
Orthopaedic Proceedings·2025
Stroma-derived Dickkopf-1 contributes to the suppression of NK cell cytotoxicity in breast cancer
Nature Communications·2025· 7 citedOpen Access
Mapping the Course of Recovery Following Limb-Salvage Surgery for Soft-Tissue Sarcoma of the Extremities
Journal of Bone and Joint Surgery·2024· 4 cited
Cancer-associated fibroblast-derived Dickkopf-1 suppresses NK cell cytotoxicity in breast cancer
2024· 1 citedOpen Access
#42. Local and systemic effects of Dickkopf-1 during breast cancer progression by limiting NK cell-mediated killing
Journal of bone oncology·2024Open Access
Figure S3 from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
2023Open Access
Figure S1 from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
2023Open Access
Figure S3 from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
2023Open Access
Figure S2 from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
2023Open Access
Figure S1 from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
2023Open Access
Figure S2 from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
2023Open Access
Data from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
2023Open Access
Data from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
2023Open Access
Supplementary Figures 1 - 12 and Tables 1 - 11 from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Supplementary Materials and Methods from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Data from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Data from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Supplementary Figures 1 - 12 and Tables 1 - 11 from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Supplementary Materials and Methods from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Nicholas P. Restifo(32), Christopher A. Klebanoff(28), Rahul Roychoudhuri(28), Madhusudhanan Sukumar(25), Douglas C. Palmer(24), Luca Gattinoni(24), Robert Eil(22), Zhiya Yu(22), Joseph G. Crompton(21), Ena Wang(19), Francesco M. Marincola(18), Alena Gros(15), Pawel Muranski(13), Ken‐ichi Hanada(13), Nicolas Acquavella(13), Anthony Leonardi(11), Shashank J. Patel(10), Steven A. Rosenberg(10), Sid P. Kerkar(9), Ryan D. Michalek(9)